Show document

A+ | A- | | SLO | ENG

Title: Prediagnosticiranje Authors: ID Glumac, Nebojša (Author) Files: PDF - Presentation file, download (508,32 KB) MD5: B8B1727791BFAE99FDD6D0D6DC2E18C5 PID: 20.500.12556/dirros/66975dd2-7f95-4caa-8cc1-6159ac6d2639   Language: Slovenian Typology: 1.01 - Original Scientific Article Organization: OI - Institute of Oncology Abstract: V tem prispevku bomo opisali pojav pri raku, ki ga po angleško imenujemo overdiagnosis. Za izraz še ni uradno sprejetega slovenskega prevoda, v tem prispevku pa bomo uporabili izraz prediagnosticiranje, ki označuje raka, ki ne bi povzročil simptomov ali smrti, če ne bi bil diagnosticiran. Za to sta potrebna 2 pogoja: obstoj večje baze subkliničnega raka in aktivno odkrivanje te baze, presejanje. Ocena prediagnosticiranja pri presejanju je znana iz randomiziranih študij: 25 % za raka dojk, 50 % za pljučnega raka in več kot 60 % za raka prostate. Retrospektivne študije in populacijska statistika kažejo na prediagnosticiranje pri nevroblastomu, ščitničnem raku, raku ledvic in melanomu. Zato je treba bolnike seznaniti z velikostjo problema in možnostmi negativnih učinkov zdravljenja bolezni, ki jih morda ne bi nikoli prizadela. Pogostost prediagnosticiranja bi bilo treba bolje oceniti in odkriti metode, s katerimi bi ta problem zmanjšali. Publication status: Published Publication version: Version of Record Year of publishing: 2012 Number of pages: str. 29-32, 58 Numbering: Letn. 16, št. 1 PID: 20.500.12556/DiRROS-8863  UDC: 616-006.6-07 ISSN on article: 1408-1741 URN: URN:NBN:SI:doc-OK91AHTJ COBISS.SI-ID: 1318523  Copyright: by Authors Publication date in DiRROS: 31.08.2018 Views: 2888 Downloads: 778 Metadata:    Cite this work Plain text BibTeX EndNote XML EndNote/Refer RIS ABNT ACM Ref AMA APA Chicago 17th Author-Date Harvard IEEE ISO 690 MLA Vancouver : Copy citation

Share: Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:	Onkologija
Shortened title:	Onkologija
Publisher:	Onkološki inštitut
ISSN:	1408-1741
COBISS.SI-ID:	65324032

Licences

License:	CC BY 4.0, Creative Commons Attribution 4.0 International
Link:	http://creativecommons.org/licenses/by/4.0/
Description:	This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Licensing start date:	31.08.2018

Secondary language

Language:	English
Title:	Overdiagnosis
Abstract:	In this article we will describe a phenomenon in cancer medicine known as overdiagnosis. As there is still no official Slovenian translation for this term, a Slovenian term “prediagnosticiranje” is used in the article, specifying cancer that does not cause symptoms or death if undiagnosed. This requires two conditions: an existence of a larger sub-clinical cancer base and active detection of this base, screening. Randomised studies have provided estimates of overdiagnosis in screening, being: 25% for breast cancer, 50% for lung cancer, and more than 60% for prostate cancer. Restrospective studies and population statistics show overdiagnosis of neuroblastoma, thyroid cancer, kidney cancer and melanoma. Therefore, the patients must be informed of the size of the problem and the possible negative effects of treatment of this disease, which might otherwise never have affected them at all. Thus, it would be necessary to provide better estimates of overdiagnosis frequency and discover the methods to minimise this problem.

Archive

niGradiv

Back